Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.

Identifieur interne : 001820 ( Main/Exploration ); précédent : 001819; suivant : 001821

A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.

Auteurs : Łukasz Jankowiak [Pologne] ; Lajos Rozsa [Hongrie] ; Piotr Tryjanowski [Pologne] ; Anders Pape M Ller [République populaire de Chine, France]

Source :

RBID : pubmed:32719490

Descripteurs français

English descriptors

Abstract

Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects.

DOI: 10.1038/s41598-020-69351-x
PubMed: 32719490
PubMed Central: PMC7385593


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.</title>
<author>
<name sortKey="Jankowiak, Lukasz" sort="Jankowiak, Lukasz" uniqKey="Jankowiak L" first="Łukasz" last="Jankowiak">Łukasz Jankowiak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biology, University of Szczecin, Wąska 13, 71-415, Szczecin, Poland. jankowiakl@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Biology, University of Szczecin, Wąska 13, 71-415, Szczecin</wicri:regionArea>
<wicri:noRegion>Szczecin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rozsa, Lajos" sort="Rozsa, Lajos" uniqKey="Rozsa L" first="Lajos" last="Rozsa">Lajos Rozsa</name>
<affiliation wicri:level="1">
<nlm:affiliation>GINOP Evolutionary Systems Research Group, Institute of Evolution, Centre for Ecological Research, Klebelsberg 3, Budapest, 8237, Hungary.</nlm:affiliation>
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>GINOP Evolutionary Systems Research Group, Institute of Evolution, Centre for Ecological Research, Klebelsberg 3, Budapest, 8237</wicri:regionArea>
<wicri:noRegion>8237</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tryjanowski, Piotr" sort="Tryjanowski, Piotr" uniqKey="Tryjanowski P" first="Piotr" last="Tryjanowski">Piotr Tryjanowski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Zoology, Poznan University of Life Sciences, Wojska Polskiego 71C, Poznan, 60-625, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Zoology, Poznan University of Life Sciences, Wojska Polskiego 71C, Poznan, 60-625</wicri:regionArea>
<wicri:noRegion>60-625</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="M Ller, Anders Pape" sort="M Ller, Anders Pape" uniqKey="M Ller A" first="Anders Pape" last="M Ller">Anders Pape M Ller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences, Beijing Normal University, Beijing, 100875, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences, Beijing Normal University, Beijing, 100875</wicri:regionArea>
<wicri:noRegion>100875</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Ecologie Systématique Evolution, Université Paris-Sud, CNRS, AgroParisTech, Université Paris-Saclay, 91405, Orsay Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Ecologie Systématique Evolution, Université Paris-Sud, CNRS, AgroParisTech, Université Paris-Saclay, 91405, Orsay Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Orsay</settlement>
</placeName>
<orgName type="university">Université Paris-Sud</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32719490</idno>
<idno type="pmid">32719490</idno>
<idno type="doi">10.1038/s41598-020-69351-x</idno>
<idno type="pmc">PMC7385593</idno>
<idno type="wicri:Area/Main/Corpus">000822</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000822</idno>
<idno type="wicri:Area/Main/Curation">000822</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000822</idno>
<idno type="wicri:Area/Main/Exploration">000822</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.</title>
<author>
<name sortKey="Jankowiak, Lukasz" sort="Jankowiak, Lukasz" uniqKey="Jankowiak L" first="Łukasz" last="Jankowiak">Łukasz Jankowiak</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Biology, University of Szczecin, Wąska 13, 71-415, Szczecin, Poland. jankowiakl@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Biology, University of Szczecin, Wąska 13, 71-415, Szczecin</wicri:regionArea>
<wicri:noRegion>Szczecin</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rozsa, Lajos" sort="Rozsa, Lajos" uniqKey="Rozsa L" first="Lajos" last="Rozsa">Lajos Rozsa</name>
<affiliation wicri:level="1">
<nlm:affiliation>GINOP Evolutionary Systems Research Group, Institute of Evolution, Centre for Ecological Research, Klebelsberg 3, Budapest, 8237, Hungary.</nlm:affiliation>
<country xml:lang="fr">Hongrie</country>
<wicri:regionArea>GINOP Evolutionary Systems Research Group, Institute of Evolution, Centre for Ecological Research, Klebelsberg 3, Budapest, 8237</wicri:regionArea>
<wicri:noRegion>8237</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tryjanowski, Piotr" sort="Tryjanowski, Piotr" uniqKey="Tryjanowski P" first="Piotr" last="Tryjanowski">Piotr Tryjanowski</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Zoology, Poznan University of Life Sciences, Wojska Polskiego 71C, Poznan, 60-625, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Institute of Zoology, Poznan University of Life Sciences, Wojska Polskiego 71C, Poznan, 60-625</wicri:regionArea>
<wicri:noRegion>60-625</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="M Ller, Anders Pape" sort="M Ller, Anders Pape" uniqKey="M Ller A" first="Anders Pape" last="M Ller">Anders Pape M Ller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences, Beijing Normal University, Beijing, 100875, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences, Beijing Normal University, Beijing, 100875</wicri:regionArea>
<wicri:noRegion>100875</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Ecologie Systématique Evolution, Université Paris-Sud, CNRS, AgroParisTech, Université Paris-Saclay, 91405, Orsay Cedex, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Ecologie Systématique Evolution, Université Paris-Sud, CNRS, AgroParisTech, Université Paris-Saclay, 91405, Orsay Cedex</wicri:regionArea>
<placeName>
<region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Orsay</settlement>
</placeName>
<orgName type="university">Université Paris-Sud</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Scientific reports</title>
<idno type="eISSN">2045-2322</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (isolation & purification)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (pathology)</term>
<term>Coronavirus Infections (virology)</term>
<term>Disease Susceptibility (economics)</term>
<term>Humans (MeSH)</term>
<term>Linear Models (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (pathology)</term>
<term>Pneumonia, Viral (virology)</term>
<term>Prevalence (MeSH)</term>
<term>Toxoplasmosis (epidemiology)</term>
<term>Toxoplasmosis (parasitology)</term>
<term>Toxoplasmosis (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (isolement et purification)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (anatomopathologie)</term>
<term>Infections à coronavirus (virologie)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Modèles linéaires (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Pneumopathie virale (anatomopathologie)</term>
<term>Pneumopathie virale (virologie)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Prédisposition aux maladies (économie)</term>
<term>Prévalence (MeSH)</term>
<term>Toxoplasmose (anatomopathologie)</term>
<term>Toxoplasmose (parasitologie)</term>
<term>Toxoplasmose (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Toxoplasmose</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en">
<term>Disease Susceptibility</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitologie" xml:lang="fr">
<term>Toxoplasmose</term>
</keywords>
<keywords scheme="MESH" qualifier="parasitology" xml:lang="en">
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
<term>Toxoplasmosis</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr">
<term>Prédisposition aux maladies</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>Toxoplasmose</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Linear Models</term>
<term>Pandemics</term>
<term>Prevalence</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Modèles linéaires</term>
<term>Pandémies</term>
<term>Prévalence</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32719490</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>08</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>08</Month>
<Day>12</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2045-2322</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>10</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</PubDate>
</JournalIssue>
<Title>Scientific reports</Title>
<ISOAbbreviation>Sci Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.</ArticleTitle>
<Pagination>
<MedlinePgn>12512</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-69351-x</ELocationID>
<Abstract>
<AbstractText>Coronaviruses may exert severely negative effects on the mortality and morbidity of birds and mammals including humans and domestic animals. Most recently CoVID-19 has killed about half million people (27th of June, 2020). Susceptibility to this disease appears to differ markedly across different societies but the factors underlying this variability are not known. Given that prevalence of toxoplasmosis in human societies may serve as a proxy for hygiene, and it also exerts both direct and immune-mediated antiviral effects, we hypothesize a negative covariation between toxoplasmosis and measures of the CoVID-19 pandemic across countries. We obtained aged-adjusted toxoplasmosis prevalence of pregnant women from the literature. Since the differences in the CoVID-19 morbidity and mortality may depend on the different timing of the epidemics in each country, we applied the date of first documented CoVID-19 in each country as a proxy of susceptibility, with a statistical control for population size effects. Using these two indices, we show a highly significant negative co-variation between the two pandemics across 86 countries. Then, considering that the wealth of nations often co-varies with the prevalence of diseases, we introduced GDP per capita into our model. The prevalence of toxoplasmosis co-varies negatively, while the date of first CoVID-19 co-varies positively with GDP per capita across countries. Further, to control for the strong spatial autocorrelation among countries, we carried out a Spatial Structure Analyses of the relationships between the date of first CoVID-19, prevalence of toxoplasmosis, and GDP per capita. Results of this analysis did not confirm a direct causal relationship between toxoplasmosis and susceptibility to the CoVID-19 pandemics. As far as an analysis of observational data let us to suggest, it appears that the interaction between CoVID-19 and toxoplasmosis is mediated by GDP per capita and spatial effects. This prompts the question whether the formerly known covariations of CoVID-19 and BCG vaccination or air pollution might have also emerged as spurious indirect effects.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Jankowiak</LastName>
<ForeName>Łukasz</ForeName>
<Initials>Ł</Initials>
<AffiliationInfo>
<Affiliation>Institute of Biology, University of Szczecin, Wąska 13, 71-415, Szczecin, Poland. jankowiakl@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rozsa</LastName>
<ForeName>Lajos</ForeName>
<Initials>L</Initials>
<AffiliationInfo>
<Affiliation>GINOP Evolutionary Systems Research Group, Institute of Evolution, Centre for Ecological Research, Klebelsberg 3, Budapest, 8237, Hungary.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tryjanowski</LastName>
<ForeName>Piotr</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Institute of Zoology, Poznan University of Life Sciences, Wojska Polskiego 71C, Poznan, 60-625, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Møller</LastName>
<ForeName>Anders Pape</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering, College of Life Sciences, Beijing Normal University, Beijing, 100875, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Ecologie Systématique Evolution, Université Paris-Sud, CNRS, AgroParisTech, Université Paris-Saclay, 91405, Orsay Cedex, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>GINOP-2.3.2-15-2016-00057</GrantID>
<Agency>GINOP</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>FVS PULS 506-511-05</GrantID>
<Agency>statutory funding</Agency>
<Country>International</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Sci Rep</MedlineTA>
<NlmUniqueID>101563288</NlmUniqueID>
<ISSNLinking>2045-2322</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014123" MajorTopicYN="N">Toxoplasmosis</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>05</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>07</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>8</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32719490</ArticleId>
<ArticleId IdType="doi">10.1038/s41598-020-69351-x</ArticleId>
<ArticleId IdType="pii">10.1038/s41598-020-69351-x</ArticleId>
<ArticleId IdType="pmc">PMC7385593</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Science. 2002 Apr 19;296(5567):490-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11964470</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2010 Oct 8;330(6001):243-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20929776</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Jun 25;181(7):1489-1501.e15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32473127</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Folia Parasitol (Praha). 2014 Dec;61(6):485-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25651689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Comput Biol Chem. 2020 Feb;84:107158</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31810853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Trop Med Hyg. 2020 Jun 01;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32484156</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2018 May 5;391(10132):1783-1798</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29678341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Sci Total Environ. 2020 Jul 20;727:138704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32315904</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Parasitol. 2013 Apr;29(4):156-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23433494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Respir J. 2008 Nov;32(5):1415-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18978146</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 May 28;181(5):969-977</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32437659</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunity. 2019 Jan 15;50(1):64-76.e4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30635240</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Folia Parasitol (Praha). 2010 Jun;57(2):105-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20608472</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 2009 Jan;29(1):55-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19014335</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Biol Sci. 2010 Sep 7;277(1694):2587-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20392728</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>One Health. 2020 Feb 14;9:100123</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32140538</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Biol Sci. 2006 Nov 7;273(1602):2749-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17015323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>One Health. 2020 Feb 24;9:100124</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32195311</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol Biotechnol. 2017 Sep 28;27(9):1549-1558</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28683527</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutrients. 2020 Apr 02;12(4):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32252338</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Infect Dis. 2020 Feb;91:264-266</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31953166</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Microbiol. 2017 Nov;55(11):909-917</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29076073</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Hongrie</li>
<li>Pologne</li>
<li>République populaire de Chine</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Orsay</li>
</settlement>
<orgName>
<li>Université Paris-Sud</li>
</orgName>
</list>
<tree>
<country name="Pologne">
<noRegion>
<name sortKey="Jankowiak, Lukasz" sort="Jankowiak, Lukasz" uniqKey="Jankowiak L" first="Łukasz" last="Jankowiak">Łukasz Jankowiak</name>
</noRegion>
<name sortKey="Tryjanowski, Piotr" sort="Tryjanowski, Piotr" uniqKey="Tryjanowski P" first="Piotr" last="Tryjanowski">Piotr Tryjanowski</name>
</country>
<country name="Hongrie">
<noRegion>
<name sortKey="Rozsa, Lajos" sort="Rozsa, Lajos" uniqKey="Rozsa L" first="Lajos" last="Rozsa">Lajos Rozsa</name>
</noRegion>
</country>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="M Ller, Anders Pape" sort="M Ller, Anders Pape" uniqKey="M Ller A" first="Anders Pape" last="M Ller">Anders Pape M Ller</name>
</noRegion>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="M Ller, Anders Pape" sort="M Ller, Anders Pape" uniqKey="M Ller A" first="Anders Pape" last="M Ller">Anders Pape M Ller</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001820 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001820 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32719490
   |texte=   A negative covariation between toxoplasmosis and CoVID-19 with alternative interpretations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32719490" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021